GSK Takes Avandia Marketing Battle To Supreme Court
GlaxoSmithKline is asking the U.S. Supreme Court to upend a Third Circuit ruling in a case over the marketing of the diabetes medication Avandia, saying the appeals court had taken an...To view the full article, register now.
Already a subscriber? Click here to view full article